Follow
Leiliane Marcatto
Leiliane Marcatto
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Genetic factors influencing warfarin dose in Black‐African patients: a systematic review and meta‐analysis
IG Asiimwe, EJ Zhang, R Osanlou, A Krause, C Dillon, G Suarez‐Kurtz, ...
Clinical Pharmacology & Therapeutics 107 (6), 1420-1433, 2020
532020
Genotype-guided warfarin therapy: current status
LC Tavares, LR Marcatto, PCJL Santos
Pharmacogenomics 19 (7), 667-685, 2018
472018
Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration
PCJL Santos, LR Marcatto, NE Duarte, RA Gadi Soares, ...
Pharmacogenomics 16 (8), 865-876, 2015
452015
Pharmaceutical care increases time in therapeutic range of patients with poor quality of anticoagulation with warfarin
LR Marcatto, L Sacilotto, LC Tavares, M Facin, N Olivetti, CMC Strunz, ...
Frontiers in pharmacology 9, 1052, 2018
322018
Association between ABCB1 polymorphism and stable warfarin dose requirements in Brazilian patients
LC Tavares, LR Marcatto, RAG Soares, JE Krieger, AC Pereira, ...
Frontiers in pharmacology 9, 374722, 2018
262018
Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation
LR Marcatto, L Sacilotto, FC da Costa Darrieux, DT Hachul, ...
Oncotarget 7 (34), 54194, 2016
262016
Machine learning for prediction of stable warfarin dose in US Latinos and Latin Americans
HE Steiner, JB Giles, HK Patterson, J Feng, N El Rouby, K Claudio, ...
Frontiers in Pharmacology 12, 749786, 2021
122021
Impact of adherence to warfarin therapy during 12 weeks of pharmaceutical care in patients with poor time in the therapeutic range
L Marcatto, B Boer, L Sacilotto, N Olivetti, FCC Darrieux, MI Scanavacca, ...
Journal of Thrombosis and Thrombolysis 51, 1043-1049, 2021
122021
Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range–study protocol for a randomized controlled trial
LR Marcatto, L Sacilotto, CT Bueno, M Facin, CMC Strunz, FCC Darrieux, ...
BMC cardiovascular disorders 16, 1-6, 2016
102016
Multi‐site investigation of genetic determinants of warfarin dose variability in Latinos
N El Rouby, L Rodrigues Marcatto, K Claudio, L Camargo Tavares, ...
Clinical and translational science 14 (1), 268-276, 2021
82021
Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population
LC Tavares, NE Duarte, LR Marcatto, RAG Soares, JE Krieger, ...
European journal of clinical pharmacology 74 (12), 1555-1566, 2018
62018
Interferência de medicamentos utilizados nos exames laboratoriais para monitoramento de dislipidemias e diabetes mellitus
PCJL Santos, AM Silva, LR Marcatto, VCM Silva, ACL Prete, ...
Unisanta Health Science 1 (1), 18-32, 2017
52017
Evaluation of the long-term impact on quality after the end of pharmacist-driven warfarin therapy management in patients with poor quality of anticoagulation therapy
LR Marcatto, L Sacilotto, LC Tavares, DSP Souza, N Olivetti, CMC Strunz, ...
Frontiers in pharmacology 11, 1056, 2020
22020
Fármacos anticoagulantes
LR MARCATTO, LC TAVARES, L SACILOTTO, PCJL SANTOS
Litro-texto farmacologia, 2021
12021
Appendix C-Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans
HE Steiner, JB Giles, HK Patterson, J Feng, N El Rouby, K Claudio, ...
Increasing Inclusion of Participants, Leveraging Gut Microbiomes, and …, 2022
2022
VALIDITY OF INTERNATIONAL WARFARIN PHARMACOGENETIC CONSORTIUM (IWPC) DOSING ALGORITHM AND APPLICATION OF MACHINE LEARNING TO PREDICT WARFARIN DOSE VARIABILITY IN US LATINO AND …
H Steiner, N El Rouby, K Claudio, L Rodrigues Marcatto, J Giles, ...
CLINICAL PHARMACOLOGY & THERAPEUTICS 109, S27-S27, 2021
2021
Fármacos antiarrítmicos
LR MARCATTO, GD PESSENTE, L SACILOTTO
Litro-texto farmacologia, 2021
2021
Avaliação do impacto do cuidado farmacêutico na qualidade da terapia com varfarina em pacientes sem dose estável
LR Marcatto
Universidade de São Paulo, 2021
2021
Farmacogenômica
LC TAVARES, LR MARCATTO, PCJL SANTOS
Litro-texto farmacologia, 2021
2021
MULTI-SITE INVESTIGATION OF PHARMACOGENETIC DETERMINANTS OF WARFARIN DOSE VARIABILITY IN LATINOS.
N El Rouby, L Marcatto, K Claudio, L Tavares, H Steiner, MR Botton, ...
CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S119-S119, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20